| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 22.684 | 14.062 | 10.134 | 9.215 | 6.802 | 4.880 |
| Total Income - EUR | - | - | - | - | 22.685 | 14.063 | 10.135 | 9.216 | 6.802 | 4.880 |
| Total Expenses - EUR | - | - | - | - | 14.829 | 10.435 | 7.584 | 7.264 | 5.310 | 3.897 |
| Gross Profit/Loss - EUR | - | - | - | - | 7.855 | 3.628 | 2.551 | 1.952 | 1.492 | 982 |
| Net Profit/Loss - EUR | - | - | - | - | 7.132 | 3.240 | 2.416 | 1.680 | 1.318 | 865 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Ldc Biosmile S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 30 | 30 | 29 | 29 | 29 | 29 |
| Current Assets | - | - | - | - | 10.603 | 13.337 | 15.707 | 14.570 | 3.493 | 4.372 |
| Inventories | - | - | - | - | 4.076 | 2.702 | 2.000 | 1.350 | 1.083 | 855 |
| Receivables | - | - | - | - | 0 | 0 | 104 | 6 | 97 | 86 |
| Cash | - | - | - | - | 6.527 | 10.635 | 13.604 | 13.214 | 2.313 | 3.431 |
| Shareholders Funds | - | - | - | - | 7.343 | 10.444 | 12.629 | 2.181 | 3.493 | 4.338 |
| Social Capital | - | - | - | - | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | - | - | - | - | 3.291 | 2.923 | 3.108 | 12.419 | 29 | 63 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4789 - 4789" | |||||||||
| CAEN Financial Year |
4789
|
|||||||||
Comments - Ldc Biosmile S.r.l.